ClinicalTrials.Veeva

Menu
O

Olive View UCLA Medical Center | Neurology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tiotropium
Paclitaxel
Platinum
Salmeterol
Remibrutinib
Isavuconazonium sulfate
Testosterone
VB-111
Voriconazole
Ivermectin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 12 total trials

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)

The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in pa...

Enrolling
Hidradenitis Suppurativa
Drug: Placebo 1
Drug: Placebo 2

The overall purpose of this two-part study is to evaluate the efficacy, safety and tolerability of iptacopan (LNP023) in addition to standard of care...

Enrolling
Lupus Nephritis
Drug: Iptacopan (part 2)
Drug: Iptacopan + placebo

Trial sponsors

Boehringer Ingelheim logo
Novartis logo
AbbVie logo
A
Astellas logo
H
Pfizer logo
University of Minnesota (UMN) logo
V
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems